bioavailability_ma_et_al

## Dataset Details

### Dataset Description

Oral bioavailability is defined as the rate and extent to which the
active ingredient or active moiety is absorbed from a drug product and becomes
available at the site of action.

- **Curated by:**
- **License:** CC BY 4.0

### Dataset Sources

- [corresponding publication](https://doi.org/10.1016/j.jpba.2008.03.023)
- [data source](https://tdcommons.ai/single_pred_tasks/adme/#bioavailability-ma-et-al)

## Citation

**BibTeX:**

```bibtex
@article{Ma2008,
doi = {10.1016/j.jpba.2008.03.023},
url = {https://doi.org/10.1016/j.jpba.2008.03.023},
year = {2008},
month = aug,
publisher = {Elsevier BV},
volume = {47},
number = {4-5},
author = {Chang-Ying Ma and Sheng-Yong Yang and Hui Zhang
and Ming-Li Xiang and Qi Huang and Yu-Quan Wei},
title = {Prediction models of human plasma protein binding rate and
oral bioavailability derived by using GA-CG-SVM method},
journal = {Journal of Pharmaceutical and Biomedical Analysis}
```

# 数据集详情
## 数据集描述
口服生物利用度（oral bioavailability）指药物制剂中的活性成分或活性部分被机体吸收并抵达作用部位的速率与程度。
- **整理方：**
- **授权协议：** CC BY 4.0

## 数据集来源
- [相关研究文献](https://doi.org/10.1016/j.jpba.2008.03.023)
- [数据来源](https://tdcommons.ai/single_pred_tasks/adme/#bioavailability-ma-et-al)

## 引用信息
### BibTeX 格式引用：
bibtex
@article{Ma2008,
doi = {10.1016/j.jpba.2008.03.023},
url = {https://doi.org/10.1016/j.jpba.2008.03.023},
year = {2008},
month = aug,
publisher = {Elsevier BV},
volume = {47},
number = {4-5},
author = {Chang-Ying Ma and Sheng-Yong Yang and Hui Zhang and Ming-Li Xiang and Qi Huang and Yu-Quan Wei},
title = {基于GA-CG-SVM方法构建的人体血浆蛋白结合率与口服生物利用度预测模型},
journal = {《药物与生物医学分析杂志》}
}